Advanced SearchSearch Tips
Isolation of Stenotrophomonas rhizopilae Strain GFC09 with Ginsenoside Converting Activity and Anti-wrinkle Effects of Converted Ginsenosides
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Isolation of Stenotrophomonas rhizopilae Strain GFC09 with Ginsenoside Converting Activity and Anti-wrinkle Effects of Converted Ginsenosides
Min, Jin Woo; Kim, Hye-Jin; Joo, Kwang-Sik; Kang, Hee-Cheol;
  PDF(new window)
Ginsenosides (ginseng saponin) as the one of important pharmaceutical compounds of ginseng and is responsible for the pharmacological and biological activities. These ginsenoside produces diverse small molecules ginsenoside which have more pharmacological activities including anti-wrinkle, anti-cancer and anti-oxidant effects. In the present study, we isolated bacteria using esculin agar, to produce -glucosidase, and we focused on the bio-transformation of ginsenoside. Phylogenetic tree analysis was performed by comparing the 16S rRNA sequences; we identified the strain as Stenotrophomonas rhizopilae strain GFC09. In order to determine the optimal conditions for enzyme activity, the crude enzyme was incubated with 1 mM ginsenoside . Bioconversion of ginsenoside were analyzed using TLC and HPLC. The crude enzyme hydrolyzed the ginsenoside along the following pathway: LB: into compound K, TSB: . The structure of the hydrolyzed metabolites were identified by NMR. The activity screening tests showed that the conversion product induced the production of type I procollagen in a dose-dependent manner. These results suggested that hydrolyzed ginseng product containing the ginsenoside and compound K could be useful as an active ingredient for wrinkle-care cosmetics.
Stenotrophomonas rhizopilae strain GFC09;ginsenoside compound K;anti-wrinkle;bioconversion;
 Cited by
J. E. Shin, E. K. Park, E. J. Kim, Y. H. Hong, K. T. Lee, and D. H. Kim, Cytotoxicity of compound K (IH-901) and ginsenoside Rh2, main biotransformants of ginseng saponins by bifidobacteria, against some tumor cells, J. Ginseng Res., 27(3), 129 (2003). crossref(new window)

M. Karikura, T. Miyase, H. Tanizawa, T. Taniyama, and Y. Takino, Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside- Rb1 and Rb2 in the digestive tract of rats, Chem. Pharm. Bull., 39(9), 2357 (1991). crossref(new window)

Y. Kikuchi, H. Sasa, T. Kita, J. Hirata, and T. Tode, Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside-Rh2 and adjuvant effects of cisplatin in vivo, Anti-cancer Drugs, 2(1), 63 (1991). crossref(new window)

V. Vuksan, M. K. Sung, J. L. Sievenpiper, P. M. A. L. Jenkins, M. D. Buono, K. S. Lee, L. A. Leiter, K. Y. Nam, J. T. Armason, M. Choi, and A. Naeem, Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo- controlled study of efficacy and safety, Nutr. Metab. Cardiovasc. Dis., 18, 46 (2008). crossref(new window)

H. Kaneko and K. Nakanishi, Proof of the mysterious efficacy of ginseng: basic and clinical trials: clinical effects of medical ginseng, Korean red ginseng: specifically, its anti-stress action for prevention of disease, J. Pharmacol. Sci., 95, 158 (2004). crossref(new window)

B. J. Park, Y. S. Lim, H. J. Lee, W. S. Eum, J. Park, K. H, Han, and K. S. Lee, Anti-oxidative effects of Phellinus linteus and red ginseng extracts on oxidative stress-induced DNA damage, BMB Rep., 42, 500 (2009). crossref(new window)

E. K. Park, M. K. Choo, M. J. Han, and D. H. Kim, Antiallergic and anti inflammatory activities of ginsenoside Rh1, Int. Arch. Allergy Immunol., 133, 113 (2004). crossref(new window)

S. Shibata, O. Tanaka, T. Ando, M. Sada, S. Tsushima, and T. Ohsawa, Chemical studies on oriental plant drugs. XIV. Protopanasadiol, a genuine sapogenin of ginseng saponins, Chem. Pharm. Bull., 14, 595 (1966). crossref(new window)

J. D. Park, D. K. Lee, and Y. H. Lee, Biological activities and chemistry of saponins from Panax ginseng C. A. Meyer, Phytochem. Reviews, 4(2), 159 (2005). crossref(new window)

Z. Y. Luo, Q. H. Lu, S. P. Liu, X. H. Chen, J. Q. Luo, L. J. Tan, and W. X. Hu, Screening and identification of novel genes involved in viosynthesis of ginsenoside in Panax ginseng plant, ACTA Biochem. Biophys. Sin., 35(6), 554 (2003).

M. K. Kim, J. W. Lee, K. Y. Lee, and D. C. Yang, Microbial conversion of major ginsenoside rb1 to pharmaceutically active minor ginsenoside Rd, J. Microbiol., 43, 456 (2005).

K. S. Kim, M. S. Kim, J. R. Lee, and C. H. Choi, Ginsenosides compound K and Rh2 inhibit tumor necrosis factor-$\alpha$-induced activation of the NF-${\kappa}B$ and JNK pathways in human astroglial cells, Neuroscience letters, 421, 37 (2007). crossref(new window)

D. He, J. Sun, X. Zhu, S. Nian, and J. Liu, Compound K increases type I procollagen level and decreases matrix metalloproteinase-1 activity and level in ultraviolet-A-irradiated fibroblasts, J. Formos. Med. Assoc., 110(3), 153 (2011). crossref(new window)

L. Q. Cheng, J. R. Na, M. K. Kim, M. H. Bang, and D. C. Yang, Microbial conversion of ginsenoside Rb1 to minor ginsenoside F2 and gypenoside XVII by Intrasporangium sp. GS603 isolated from Soil, J. Microbiol. Biotech., 17(12), 1937 (2007).

M. Mochizuki, Y. C. Yoo, and K. Matsuzawa, Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside Rb2, 20(R)- and 20(S)-ginsenoside Rg3, of red ginseng, Biol. Pharm. Bull., 18(9), 1197 (1995). crossref(new window)

J. H. Su, J. H. Xu, W. Y. Lu, and G. Q. Lin, Enzymatic transformation of ginsenoside Rg3 to Rh2 using newly isolated Fusarium proliferatum ECU2042, J. Molecul. Catal., 38, 113 (2006). crossref(new window)

M. Kimura, Preponderance of synonymous changes as evidence for the neutral theory of molecular evolution, Nature, 267, 275 (1977). crossref(new window)

S. Kumar, K. Tamura, and M. Nei, MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment, Brief. Bioinform., 5(2), 150 (2004). crossref(new window)

K. Meada and M. Fukuda, In vitro effectiveness of whitening cosmetic components in human melanocyte, J. Soc. Cosmet. Chem., 42(6), 361 (1991).

L. Q. Cheng, J. R. Na, M. H. Bang, M. K. Kim, and D. C. Yang, Conversion of major ginsenoside Rb1 to 20 (S)-ginsenoside Rg3 by Microbacterium sp. GS514, Phytochemistry, 69(1), 218 (2008). crossref(new window)

S. R. Ko, Y. Suzuki, K. Suzuki, K. J. Choi, and B. G. Cho, Marked production of ginsenosides Rd, F2, Rg3, and compound K by enzymatic method, Chem. Pharm. Bull., 55(10), 1522 (2007). crossref(new window)